SECsense Logo

CG Oncology, Inc. 8-K Filing: Key Updates as of January 9, 2025

$CGON
Form 8-K
Filed on: 2025-01-10
Source
CG Oncology, Inc. 8-K Filing: Key Updates as of January 9, 2025

Based on the provided section of the financial report, here are the key insights and information extracted:

  1. Entity Information:
  • Company Name: CG Oncology, Inc.
  • CIK (Central Index Key): 0001991792
  • SEC File Number: 001-41925
  • EIN (Employer Identification Number): 37-1611499
  • Address: 400 Spectrum Center Drive, Suite 2040, Irvine, CA 92618
  • Phone Number: (949) 409-3700
  1. Filing Type:
  • Form Type: 8-K (current report for significant events that shareholders should know about)
  • Filing Date: January 9, 2025
  1. Stock Information:
  • Common Stock Par Value: $0.0001 per share
  • Ticker Symbol: CGON
  • Exchange: NASDAQ
  1. Reporting Period:
  • Start Date: January 9, 2025
  • End Date: January 9, 2025 (indicating this report pertains to a specific event on this date)
  1. XBRL and XML Metadata:
  • The report is formatted in XBRL (eXtensible Business Reporting Language) for structured data reporting, which is standard for SEC filings.

Summary:

This document is an 8-K filing by CG Oncology, Inc. to report significant corporate events as of January 9, 2025. The company operates under the ticker symbol CGON on NASDAQ and has a nominal par value of $0.0001 per share for its common stock. The filing provides essential information regarding the company’s identity and current legal status as required by the SEC.